Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | diacylglycerol O-acyltransferase 1 | Starlite/ChEMBL | References |
Homo sapiens | diacylglycerol O-acyltransferase 1 | Starlite/ChEMBL | References |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | diacylglycerol O-acyltransferase, putative | 0.0307 | 1 | 0.5 |
Echinococcus granulosus | diacylglycerol O acyltransferase 1 | 0.0307 | 1 | 0.5 |
Loa Loa (eye worm) | diacylglycerol acyltransferase | 0.0307 | 1 | 1 |
Plasmodium falciparum | diacylglycerol O-acyltransferase | 0.0307 | 1 | 0.5 |
Schistosoma mansoni | diacylglycerol O-acyltransferase 1 | 0.0307 | 1 | 0.5 |
Echinococcus multilocularis | diacylglycerol O acyltransferase 1 | 0.0307 | 1 | 0.5 |
Toxoplasma gondii | acyl-CoA:cholesterol acyltransferase alpha ACAT1-alpha | 0.0307 | 1 | 0.5 |
Toxoplasma gondii | acyl-CoA:diacylglycerol acyltransferase 1-related enzyme | 0.0307 | 1 | 0.5 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
EC50 (ADMET) | > 100 uM | Induction of CYP3A4 (unknown origin) | ChEMBL. | 23810496 |
EC50 (ADMET) | > 100 uM | Induction of CYP2E1 (unknown origin) | ChEMBL. | 23810496 |
EC50 (ADMET) | > 100 uM | Induction of CYP2C9 (unknown origin) | ChEMBL. | 23810496 |
EC50 (ADMET) | > 100 uM | Induction of CYP2B6 (unknown origin) | ChEMBL. | 23810496 |
EC50 (ADMET) | > 100 uM | Induction of CYP1A2 (unknown origin) | ChEMBL. | 23810496 |
IC50 (binding) | = 0.112 uM | Inhibition of recombinant human DGAT-1 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis | ChEMBL. | 23810496 |
IC50 (binding) | = 0.568 uM | Inhibition of DGAT-1 in mouse liver microsomes using didecanoyl glycerol and [14C]decanoyl-CoA as substrate after 60 mins by liquid scintillation counting analysis | ChEMBL. | 23810496 |
IC50 (binding) | > 20 uM | Inhibition of recombinant human DGAT-2 expressed in Hep3B cell lysate using didecanoyl glycerol and [14C]oleoyl-CoA as substrate after 120 mins by liquid scintillation counting analysis | ChEMBL. | 23810496 |
IC50 (ADMET) | > 69.3 uM | Inhibition of CYP2C19 (unknown origin) | ChEMBL. | 23810496 |
IC50 (ADMET) | > 100 uM | Inhibition of CYP3A4 (unknown origin) | ChEMBL. | 23810496 |
IC50 (ADMET) | > 100 uM | Inhibition of CYP2D6 (unknown origin) | ChEMBL. | 23810496 |
IC50 (ADMET) | > 100 uM | Inhibition of CYP2C9 (unknown origin) | ChEMBL. | 23810496 |
IC50 (ADMET) | > 100 uM | Inhibition of CYP1A2 (unknown origin) | ChEMBL. | 23810496 |
IC50 (binding) | > 100 uM | Binding affinity to human ERG | ChEMBL. | 23810496 |
IC50 (ADMET) | > 100 uM | Cytotoxicity against human HFL1 cells | ChEMBL. | 23810496 |
IC50 (ADMET) | > 100 uM | Cytotoxicity against mouse NIH/3T3 cells | ChEMBL. | 23810496 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.